Timely access to high-quality peptides is essential in drug discovery, especially for screening, structure-activity relationship (SAR) studies, and early-stage preclinical research. Any delay in ...
Oversubscribed £2.5M seed round led by Ahren Innovation Capital Strategic collaboration with o2h to progress drug discovery programme OutSee, a genomics and drug discovery company pioneering a unique ...
Peptides have emerged as indispensable tools in modern drug discovery, playing a central role in areas such as oncology, metabolic disorders, targeted delivery, and protein–protein interaction ...
He further stated that the o2h group seeds new ideas in science, technology and social enterprise. The company works across boundaries and takes a collaborative and shared approach to innovation, and ...
CAMBRIDGE, England, January 12, 2026--(BUSINESS WIRE)--OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, today announced the ...
OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, today announced the closure of its £2.5 M seed funding round. The Company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results